Page last updated: 2024-08-23

phenyl acetate and Opioid-Related Disorders

phenyl acetate has been researched along with Opioid-Related Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bansal, N; Bansal, S; Kumar, M; Rehni, AK; Singh, I; Singh, N1
Del Bianco, PL; Nicolodi, M; Sicuteri, F1

Other Studies

2 other study(ies) available for phenyl acetate and Opioid-Related Disorders

ArticleYear
Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    European journal of pharmacology, 2008, Nov-19, Volume: 598, Issue:1-3

    Topics: Acetates; Animals; Cyclopropanes; Female; Leukotriene Antagonists; Leukotriene D4; Male; Mice; Motor Activity; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Pain Measurement; Pain Threshold; Quinolines; Signal Transduction; Substance Withdrawal Syndrome; Sulfides; Tetrahydroisoquinolines

2008
Modulation of excitatory amino acids pathway: a possible therapeutic approach to chronic daily headache associated with analgesic drugs abuse.
    International journal of clinical pharmacology research, 1997, Volume: 17, Issue:2-3

    Topics: Acetates; Adult; Amines; Chronic Disease; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Lamotrigine; Male; Middle Aged; Migraine Disorders; Opioid-Related Disorders; Substance Withdrawal Syndrome; Triazines

1997